Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function

International Journal of Cancer

Volumn 68, Issue 2, 1996, Pages 245-250

  Komarov, Pavel G ^a   Shtil, Alexander A ^b   Buckingham, Lela E ^a   Balasubramanian, M ^c   Piraner, Olga ^c   Martin Emanuele, R ^c   Roninson, Igor B ^b   Coon, John S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CytRx Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; POLOXAMER; POLYETHYLENE GLYCOL FATTY ACID DIESTER; STAUROSPORINE; UNCLASSIFIED DRUG; VALSPODAR; VERAPAMIL;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CYTARABINE; DOXORUBICIN; FATTY ACIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; NEOPLASMS; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS; TUMOR CELLS, CULTURED;

EID: 0029817217     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961009)68:2<245::AID-IJC18>3.0.CO;2-9     Document Type: Article

References (21)

1. AKIYAMA, S.-L, FOJO, A., HANOVER, J.A., PASTAN, I. and GOTTESMAN, M.M., Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell mol. Genet., 11, 117-126 (1985).
2. BECK, W.T., CIRTAIN, M.C. and LEFKO, J.L., Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts. Mol. Pharmacol., 24, 485-493 (1983).
3. BHAT, U.G., WINTER, M.A., PEARCE, H.L. and BECK, W.T., A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in human colon carcinoma cell line. Mol. Pharmacol., 48, 682-689 (1995).
4. BUCKINGHAM, L.E., BALASUBRAMANIAN, M., EMANUELE, R.M., CLODFELTER, K.E. and COON, J.S., Comparison of Solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents. Int. 3. Cancer, 62, 436-442 (1995).
5. BUCKINGHAM, L.E., BALASUBRAMANIAN, M., SAFA, A.R., SHAH, H., KOMAROV, P., EMANUELE, R.M. and COON, J.S., Reversal of multidrug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int. J. Cancer, 65, 74-79 (1996).
6. CHAUDHARY, P.M. and RONINSON, I.B., Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncology Res., 4, 281-290 (1992).
7. CHAUDHARY, P.M. and RONINSON, I.E., Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. nat. Cancer Inst., 85, 632-639 (1993).
8. COON, J.S., BALASUBRAMANIAN, M. and EMANUHLE, R.M., Novel reverse poloxamers hypersensitize multidrug resistant tumor cells to drugs. Proc. Amer. Assoc. Cancer Res., 37, 330 (1996).
9. COON, J.S., KNUDSON, W., CLODFELTER, K., LU, B. and WEINSTEIN, R.S., Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res., 51, 897-902 (1991).
10. DUDEJA, P.K., ANDERSON, K.M., HARRIS, J.S., BUCKINGHAM, L. and COON, J.S., Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch. Biochem. Biophys., 319, 309-315 (1995).
11. HERZOG, C.E., TSOKOS, M., BATES, S.E. and FOJO, A.T., Increased mdr1-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J. biol. Chem., 268, 2946-2952 (1993).
12. HU, X.F., SLATER, A., WALL, D.M., KANTHARIDIS, P., PARKIN, J.D., COWMAN, A. and ZALCBERG, J.R., Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Brit. J. Cancer, 71, 931-936 (1995).
13. MALKEMUS, J.D., Production of alkylene oxide derivatives. J. Amer. Oil Chem. Soc., 33, 571-574 (1956).
14. MULLER, C., GOUBIN, F., FERRANDIS, E., CORNIL-SCHARWITZ, I., BAILLY, J.D., BORDIER, C., BÉNARD, J., SIKIC, B.I. and LAURENT, G., Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Mol. Pharmacol., 47, 51-56 (1995).
15. NEYFAKH, A.A., Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res., 174, 168-176 (1988).
16. NOONAN, K.E., BECK, C., HOLZMAYER, T.A., CHIN, J.E., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, LB., Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. not. Acad. Sci. (Wash.), 87, 7160-7164 (1990).
17. RONINSON, I.B., Molecular and cellular biology of multidrug resistance in tumor cells, Plenum, New York (1991).
18. SCHINKEL, A.H. and BORST, P., Multidrug resistance mediated by P-glycoproteins. Semin. Cancer Biol., 2, 213-226 (1991).
19. SCHMOLKA, I.R., Polyalkylene oxide block copolymers. In: M.J. Schick (ed.), Nonionic surfactants, 1, Dekker, New York (1966).
20. VICHI, P.J. and TRITTON, T.R., Protection from Adriamycin cytotoxicity in L1210 cells by brefeldin A. Cancer Res., 53, 5237-5243 (1993).
21. WRIGLEY, A.N., SMITH, F.D. and STIRTON, A.J., Synthetic detergents from animal fats. J. Amer. Oil Chem. Soc., 34, 39-43 (1957).